Top 10 Books about Stock Investing to read in 2018. Read more.

VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 06'th Mar 2018

PERIOD 2017-12-07 - 2018-03-06
CHANGE -5.61%
PRICE $6.06






Viking Therapeutics Stock Analysis

Technical stock analysis for Tue 06'th Mar 2018

Hold candidate since 2018-03-06

Viking Therapeutics fell by -5.61% in the last day from $6.42 to $6.06 The price has fallen in 5 of the last 10 days and is down by -5.9% for this period. Volume has increased in the last day by 0.45 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.34 million shares bought and sold for approximately $8.10 million.

Shorts 1.27% ( 2018-02-15 )
Cash 47.4 mill
Loans 7.0 mill
Beta 1.84
ROA -139.45


Viking Therapeutics has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $6.06. A reaction back to this level may hold a second chance to get out before further falls.

Click here for today's Top 5 Trending Companies


There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Monday March 05, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Viking Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $6.34. On a fall, the stock will find some support from the long-term average at approximately $5.86. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Friday February 23, 2018 and based on theory for this formation the price should fall by -1.01% to $5.92 within 11 trading days since signal was issued (Monday March 12, 2018).

Relative Strength Index (RSI)

RSI14 is 49 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Viking Therapeutics finds support from accumulated volume at $5.97. On the upside the stock meets some resistance just above today's level from accumulated volume at $6.07, $6.35 and $6.92.

The stock is about to test the resistance from accumulated volume at $6.07 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $5.97 Price: $6.06 Resistance: $6.07


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.63 between high and low, or 10.66%. For the last week, the stock has had a daily average volatility of 7.32%.

Our recommended stoploss: $5.65 (-6.69%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Viking Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.

Trade VKTX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).